PAR 3.64% 28.5¢ paradigm biopharmaceuticals limited..

Ann: PARADIGM REPORTS IND APPLICATION UPDATE, page-80

  1. 9,686 Posts.
    lightbulb Created with Sketch. 1234
    I feel some rusted on holders are misinterpreting market reaction here.

    The registry is currently made up of a substantial volume of binary traders. Moreover, the delays reinforce the inability of many insto (fund) to invest in PAR given the career risk it presents with short term underperformance filters.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.